drugset
drugset / Trial / NCT01810666

Prophylaxis Versus on Demand Treatment for Children With Hemophilia A

NCT01810666 ↗

Phase 4 Completed 30 enrolled Bayer
NaSingle-groupOpen-labelTreatment

Summary

Comparison of the effect of three times a week prophylaxis on all bleeds with on-demand treatment for children with severe Hemophilia A.

Timeline

Start
2013-03
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject ADVATE Protein / enzyme biologic 25 iu/kg —

Indications

hemophilia A